Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A diphtheria toxin-derived T-helper epitope is a short peptide sequence derived from the diphtheria toxin (DT), specifically designed to be recognized by CD4+ T-helper cells. These epitopes are commonly used as immunological adjuvants or carrier sequences in vaccine design to enhance immune responses against weakly immunogenic antigens. The most widely referenced epitope is DT(331–345), corresponding to amino acids 331 through 345 of the diphtheria toxin protein. It acts as a "universal" helper epitope, stimulating human CD4+ T cells across diverse HLA backgrounds. When covalently linked to poorly immunogenic antigens, it enhances both humoral and cellular immune responses. Applications include cancer vaccines, allergy vaccines, and general immunogenicity enhancement.
Enhances antigen presentation on MHC class II molecules, leading to CD4+ T cell activation and subsequent B cell and cytotoxic T lymphocyte stimulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diphtheria Toxin-Derived T-Helper Epitope (None).